-
Long-term outcomes after treatment of bare-metal stent restenosis with paclitaxel-coated balloon catheters or everolimus-eluting stents: 3-year follow-up of the TIS clinical studyPleva L, Kukla P, Zapletalova J et al. -
Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trialRissanen TT, Uskela S, DEBUT trial investigators.
-
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trialde Winter RJ, Katagiri Y, Serruys PW et al.
-
Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trialB Scheller, MA Ohlow, S Ewen et al.
-
Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic ReviewMohiaddin H, Wong TDFK, Burke-Gaffney A et al.
-
Drug-Coated Balloons: A Safe and Effective Alternative to Drug-Eluting Stents in Small Vessel Coronary Artery DiseaseSinaga DA, Ho HH, Watson TJ et al.
-
Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus GroupRV Jeger, S Eccleshall et al for the International DCB Consensus Group
-
Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloonsSchröder J, Vogt F, Burgmaier M et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
